PGNY
Progyny, Inc.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$25.94
−2.52%Year over year
Reported trailing growth
- Revenue
- +5.5%
- EBITDA
- +48.0%
- EBIT
- +46.1%
- EPS
- +56.5%
- Free cash flow
- +14.6%
- Operating cash flow
- +22.4%
Forward estimates
Based on analyst estimates
- Revenue
- +9.7%
- EBITDA
- +17.6%
- EPS
- +42.9%
Three-year CAGR
- Revenue
- +17.9%
- EBITDA
- +56.8%
- EBIT
- +54.0%
- Net income
- +24.5%
- EPS
- +27.3%
- Free cash flow
- +35.5%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026